Live Breaking News & Updates on Arman Parve

Stay updated with breaking news from Arman parve. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Flashback 26 July 2005: Saw fishes and turtles on roads, say Bandra residents

17 years later, some of the locals recalled the horrific experience they witnessed during Mumbai floods. ....

Pappu Baberwal , Sharik Shaikh , Bandra Talao , Bandra Talao , Arman Parve , Bandra Talao , 005 Mumbai Floods Documentary , 005 Mumbai Floods Video , 005 Flood Mumbai Pictures , 6 July 2005 Mumbai Floods , 6 July 2005 Mumbai Floods Images , 6th July 2005 Mumbai Floods Images , Umbai Floods 2005 Ppt , Umbai Floods 2005 Causes , Umbai Floods 2005 Case Study Pdf , Ighest Rainfall In Mumbai 2005 , Umbai Rain In 2005 , 005 Mumbai Floods Analysis , 005 Mumbai Floods Article , 005 Mumbai Flood Affected Areas , 005 Mumbai Flood Attack , 005 Mumbai Floods Brief , 005 Mumbai Floods Brief Summary , 005 Mumbai Flood Case Study Pdf , 005 Mumbai Flood Case Study , 005 Mumbai Flood Current News ,

PIL in Bombay HC urges quashing of differential pricing of vaccines

The rates are discriminatory and arbitrary, says the petition ....

Fayzan Khan , Trupti Gaikar , Bushra Sayed , Bombay High Court On , National Disaster Management , Serum Institute Of India , Bombay High Court , Arman Parve , Serum Institute , Bharat Biotech , National Disaster Management Act , Essential Commodities Act , Bombay Hc , Covid 19 , Coronavirus Vaccine , குண்டு உயர் நீதிமன்றம் ஆன் , தேசிய பேரழிவு மேலாண்மை , சீரம் நிறுவனம் ஆஃப் இந்தியா , குண்டு உயர் நீதிமன்றம் , சீரம் நிறுவனம் , பாரத் பயோடெக் , தேசிய பேரழிவு மேலாண்மை நாடகம் , அவசியம் பொருட்கள் நாடகம் , குண்டு ஹ்ஸீ ,

HC refuses to hear plea seeking uniform rate of COVID-19 vaccines

Updated:
Share Article
AAA
The Bombay High Court on Thursday refused to hear a public interest litigation (PIL) petition seeking to quash the different rates of COVID-19 vaccines by Serum Institute of India (SII) and Bharat Biotech for the Centre and State governments and fix the price at ₹150 per dose.
A Division Bench of Chief Justice Dipankar Datta and Justice G.S. Kulkarni said, “The Supreme Court has said that issues that have pan-India effect will be dealt with by it and pricing is a phenomenon applicable all over India. We are not entertaining it (PIL) as the apex court has fairly covered it.” ....

Justice Dipankar Datta , Fayzan Khan , Trupti Gaikar , Justicegs Kulkarni , Bushra Sayed , A Division Bench , Supreme Court , Bombay High Court On , National Disaster Management , Bharat Biotech For The Centre , Serum Institute Of India , Bombay High Court , Serum Institute , Bharat Biotech , Division Bench , Chief Justice Dipankar Datta , Arman Parve , National Disaster Management Act , Essential Commodities Act , நீதி டிபங்கர் தத்தா , உச்ச நீதிமன்றம் , குண்டு உயர் நீதிமன்றம் ஆன் , தேசிய பேரழிவு மேலாண்மை , சீரம் நிறுவனம் ஆஃப் இந்தியா , குண்டு உயர் நீதிமன்றம் , சீரம் நிறுவனம் ,